Resolute's Q3 Fee-Related EPS Surges but GAAP Loss Widens, Valuation Still Extreme

What happened

Resolute Holdings reported Q3 2026 results with non-GAAP fee-related EPS of $0.69, sharply up from $0.13 in the prior-year quarter, reflecting the first full quarter of fees from both CompoSecure and Husky under its management agreements. However, GAAP EPS attributable to common stockholders worsened to a loss of $0.74 from a loss of $0.03 a year earlier, underscoring a widening gap between fee-related earnings and bottom-line results due to escalating non-cash charges, likely including amortization of the Husky management contract and stock-based compensation. The fee-related earnings metric, which RHLD highlights, appears to annualize to roughly $2.76 per share, aligning with prior base-case estimates but still leaving the stock trading at an extreme multiple relative to that non-GAAP figure even at the previously noted price of $194.52. The master report's core concerns remain unchanged: RHLD has no direct claim on GPGI's assets, holds minimal standalone cash, and its entire economics depend on 2.5% fees from two highly leveraged, cyclical businesses. While the jump in fee-related EPS demonstrates the scalability of the management model, the concurrent deterioration in GAAP losses signals that underlying costs and non-cash burdens are growing, potentially eroding the quality of earnings that the market may be extrapolating.

Implication

Investors should treat the $0.69 fee-related EPS with caution, as it is a non-GAAP metric that excludes significant non-cash items, stock-based compensation, and possibly integration costs, while GAAP losses of $0.74 per share reveal the true economic burden on the holding company. Even if fee-related earnings annualize to $2.76 per share, at the current price of $194.52 the stock trades at approximately 70x that non-GAAP measure, leaving no margin of safety and embedding flawless execution of the Husky integration and continued EBITDA growth at GPGI. The master report's base-case scenario implied value of $180 and bear-case of $120 suggest the stock is already pricing in optimistic outcomes, while the Q3 results show no evidence of deleveraging progress or improved capital efficiency at the platform level. Moreover, RHLD's standalone balance sheet remains thin, with minimal cash and a $5 million revolver that could face covenant pressure if management fees were disrupted, making the stock an asymmetric bet skewed to the downside from current levels. Until there is visible progress on GPGI's deleveraging, reduction in non-cash charges, and a clear path to fee-related earnings that justify the multiple, investors should avoid new positions and consider trimming existing holdings.

Thesis delta

Thesis direction remains unchanged: strong sell with high conviction. The Q3 2026 results confirm the fee model is scaling as Husky contributes, but they also reveal that GAAP losses are widening, which was not fully anticipated and indicates rising non-cash expenses. This does not shift our bearish stance; rather, it adds a note of caution that the quality of reported non-GAAP earnings may be deteriorating even as the headline fee metric improves. The valuation remains unsupported by fundamentals, and the risk/reward still favors multiple compression.